Respiratory Syncytial Virus (RSV) | January 18, 2024
Date of Presentation: January 18, 2024
Type: Past Presentation
Audience: Clinical
Program: Infectious Disease
Keywords: #covid #respiratory #rsv #virus
In this series of presentations, Dr. Jonathan Iralu, Chief Clinical Consultant for Infectious Diseases at IHS, provides a clinical update on emerging COVID-19, and infectious disease topics. Then, Dr. James McAuley, Chief Medical Officer at the Whiteriver Service Unit, IHS, and Professor of Medicine with the University of Arizona, Tucson, provides the latest update on Respiratory Syncytial Virus (RSV), including a case discussion, background of the virus, the burden of RSV in U.S. children and adults, and prevention.
Recording:
Presented by:
James McAuley, MD, MPH | Jonathan Iralu, MD, MACP, FISDA
Dr. Jonathan Iralu, MD, MACP, FISDA, is the Indian Health Service (IHS) Chief Clinical Consultant for Infectious Diseases. He has a special interest in HIV, tuberculosis, and sexually transmitted disease care in rural communities. His research has focused on undifferentiated febrile illness in the American Southwest and on rural HIV care delivery. He has worked at Gallup Indian Medical Center since 1994 and is an instructor at Harvard Medical School and Senior Physician at Brigham and Women’s Hospital Division of Global Health Equity in Boston, Massachusetts.
Dr. James McAuley, MD, MPH, FIDS is the Chief Medical Officer at the Whiteriver Service Unit, IHS, as well as a Professor of Medicine with the University of Arizona, Tucson
Resources Provided:
- COVID-19 and ID Update (Presentation Slides Available Soon)
- Respiratory Syncytial Virus (Presentation Slides)
Date added: January 12, 2024